CD34 and acute coronary syndrome: In patients with acute coronary syndrome, there was no significant difference in stent endothelial coverage between CD34 antibody-covered sirolimus-eluting stents and everolimus-eluting stents at 60 days, as analyzed via optical coherence tomography (Jaguszewski et al., 2017).